[ENZYME THERAPY OF POSTCHOLECYSTECTOMY SYNDROME IN CHILDREN]

Area of Science:

• Pediatric Gastroenterology
• Pharmacology
• Digestive Health

Context:

• Postcholecystectomy syndrome (PHES) can significantly impact children's digestive health after gallbladder removal.
• Exocrine pancreatic insufficiency is a common complication requiring therapeutic intervention.
• Optimizing treatment strategies for pediatric PHES is crucial for improving patient outcomes.

Purpose:

• To provide pathogenetic justification for the efficacy of enzyme replacement therapy (ERT) in pediatric postcholecystectomy syndrome (PHES).
• To evaluate the applicability and effectiveness of ERT in children across different age demographics with PHES.
• To detail the mechanism of action, potential side effects, and benefits of specific ERT agents, like Creon, in managing PHES.

Summary:

• The article advocates for enzyme replacement therapy (ERT) as a key treatment for postcholecystectomy syndrome (PHES) in pediatric patients.
• It highlights the successful application of ERT, specifically Creon, in addressing exocrine pancreatic dysfunction in children with PHES.
• The study discusses the safety profile and therapeutic advantages of ERT, emphasizing its role in different pediatric age groups.

Impact:

• Establishes a strong rationale for incorporating ERT into the standard care for pediatric PHES.
• Provides evidence supporting the use of Creon for improving pancreatic function and alleviating symptoms in affected children.
• Offers insights into age-specific considerations for ERT administration in pediatric gastroenterology practice.